
Thermo Fisher Scientific TMO
$ 470.0
0.0%
Annual report 2025
added 02-26-2026
Thermo Fisher Scientific PEG Ratio 2011-2026 | TMO
Annual PEG Ratio Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.76 | 2.96 | 3.41 | 1.83 | 1.22 | 1.51 | 1.31 | 1.13 | 3.75 | 8.67 | 6.34 | 0.755 | 3.64 | -3.03 | 0.42 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.76 | -3.03 | 2.91 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-0.319 | $ 13.65 | - | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 25.83 | - | $ 717 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
1.12 | $ 66.34 | - | $ 25.9 B | ||
|
Guardant Health
GH
|
-3.43 | $ 87.18 | 1.98 % | $ 10.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 151.97 | - | $ 7.53 B | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 17.32 | - | $ 923 M | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 97.61 | - | $ 8.05 B | ||
|
IQVIA Holdings
IQV
|
1.57 | $ 164.89 | - | $ 28.3 B | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | $ 103.85 | - | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 14.95 | - | $ 452 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
1.09 | $ 17.29 | - | $ 2.24 B | ||
|
Anixa Biosciences
ANIX
|
-0 | $ 2.84 | - | $ 92.2 K | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.11 | - | $ 1.98 B | ||
|
Danaher Corporation
DHR
|
210 | $ 191.39 | - | $ 136 B | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
Pacific Biosciences of California
PACB
|
-0.0332 | $ 1.36 | - | $ 408 M | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
2.16 | $ 119.28 | - | $ 19 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 198.94 | - | $ 22.1 B | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
2.05 | $ 111.83 | - | $ 34 B | ||
|
BioNano Genomics
BNGO
|
-0.000017 | $ 1.11 | - | $ 1.41 M | ||
|
DarioHealth Corp.
DRIO
|
0.0333 | $ 8.42 | -6.44 % | $ 239 M | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 78.5 | - | $ 5.3 B | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
0.00787 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 453.64 | - | $ 13.1 B | ||
|
Twist Bioscience Corporation
TWST
|
-2.4 | $ 45.01 | - | $ 2.69 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 198.71 | - | $ 24.7 B | ||
|
Celcuity
CELC
|
-0.0933 | $ 114.9 | - | $ 4.53 B | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
-7.14 | $ 17.4 | - | $ 389 M | ||
|
NeoGenomics
NEO
|
0.0904 | $ 8.24 | - | $ 1.06 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-0.401 | $ 197.68 | - | $ 19.5 B |